Literature DB >> 8976225

Internal urethrotomy versus dilation as treatment for male urethral strictures: a prospective, randomized comparison.

J W Steenkamp1, C F Heyns, M L de Kock.   

Abstract

PURPOSE: We compared the efficacy of dilation versus internal urethrotomy as initial outpatient treatment for male urethral stricture disease.
MATERIALS AND METHODS: A total of 210 men with proved urethral strictures was randomized to undergo filiform dilation (106) or optical internal urethrotomy (104) with local anesthesia on an outpatient basis.
RESULTS: Life table survival analysis showed no significant difference between the 2 treatments with regard to stricture recurrence. Hazard function analysis showed that the risk of stricture recurrence was greatest at 6 months, whereas the risk of failure after 12 months was slight. The recurrence rate at 12 months was approximately 40% for strictures shorter than 2 cm. and 80% for those longer than 4 cm., whereas the recurrence rate for strictures 2 to 4 cm. long increased from approximately 50% at 12 months to approximately 75% at 48 months. Cox regression analysis showed that for each 1 cm. increase in length of the stricture the risk of recurrence was increased by 1.22 (95% confidence interval 1.05 to 1.43).
CONCLUSIONS: There is no significant difference in efficacy between dilation and internal urethrotomy as initial treatment for strictures. Both methods become less effective with increasing stricture length. We recommend dilation or internal urethrotomy for strictures shorter than 2 cm., primary urethroplasty for those longer than 4 cm. and a trial of dilation or urethrotomy for those 2 to 4 cm. long.

Entities:  

Mesh:

Year:  1997        PMID: 8976225

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  80 in total

Review 1.  Management of Urethral Stricture and Bladder Neck Contracture Following Primary and Salvage Treatment of Prostate Cancer.

Authors:  Brendan Michael Browne; Alex J Vanni
Journal:  Curr Urol Rep       Date:  2017-10       Impact factor: 3.092

2.  Multi-Institutional Outcomes of Endoscopic Management of Stricture Recurrence after Bulbar Urethroplasty.

Authors:  Shyam Sukumar; Sean P Elliott; Jeremy B Myers; Bryan B Voelzke; Thomas G Smith; Alexandra M C Carolan; Michael Maidaa; Alex J Vanni; Benjamin N Breyer; Bradley A Erickson
Journal:  J Urol       Date:  2018-05-03       Impact factor: 7.450

Review 3.  [Urethral trauma].

Authors:  G-M Pinggera; P Rehder; G Bartsch; C Gozzi
Journal:  Urologe A       Date:  2005-08       Impact factor: 0.639

Review 4.  Standing the test of time: the long-term results of urethroplasty.

Authors:  D N Wood; D E Andrich; T J Greenwell; A R Mundy
Journal:  World J Urol       Date:  2006-03-01       Impact factor: 4.226

Review 5.  Management of urethral strictures.

Authors:  A R Mundy
Journal:  Postgrad Med J       Date:  2006-08       Impact factor: 2.401

6.  Expanding the role of photoselective vaporization of the prostate.

Authors:  Steven A Kaplan
Journal:  Rev Urol       Date:  2006

Review 7.  The current role of urethrotomy in anterior urethral stricture disease.

Authors:  Sean P Elliott; Jack W McAninch
Journal:  Curr Urol Rep       Date:  2006-09       Impact factor: 3.092

8.  [Low-dose rate brachytherapy with locally integrated beta emitters after internal urethrotomy. A pilot project using an animal model].

Authors:  P Weidlich; C Adam; R Sroka; I Lanzl; W Assmann; C Stief
Journal:  Urologe A       Date:  2007-09       Impact factor: 0.639

9.  The UREThRAL stricture score: A novel method for describing anterior urethral strictures.

Authors:  Lucas R Wiegand; Steven B Brandes
Journal:  Can Urol Assoc J       Date:  2012-08       Impact factor: 1.862

10.  A prospective, randomized trial to evaluate the efficacy of clean intermittent catheterization versus triamcinolone ointment and contractubex ointment of catheter following internal urethrotomy: long-term results.

Authors:  Osman Ergün; Ahmet Güzel; Abdullah Armağan; Alim Koşar; Ayşe Gül Ergün
Journal:  Int Urol Nephrol       Date:  2015-04-26       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.